132 related articles for article (PubMed ID: 10875318)
21. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
22. [Bone mineral density in patients with rheumatoid arthritis].
Macovei L; Ancuţa C; Belibou C; Chirieac R
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):723-30. PubMed ID: 22046778
[TBL] [Abstract][Full Text] [Related]
23. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study.
Kröger H; Honkanen R; Saarikoski S; Alhava E
Ann Rheum Dis; 1994 Jan; 53(1):18-23. PubMed ID: 8311549
[TBL] [Abstract][Full Text] [Related]
24. Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.
Lambrinoudaki I; Christodoulakos G; Aravantinos L; Antoniou A; Rizos D; Chondros C; Kountouris A; Chrysofakis G; Creatsas G
J Bone Miner Metab; 2006; 24(1):65-71. PubMed ID: 16369901
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation?
Lespessailles E; Poupon S; Adriambelosoa N; Pothuaud L; Siroux V; Bouillon S; Benhamou CL
Joint Bone Spine; 2000; 67(2):119-26. PubMed ID: 10769104
[TBL] [Abstract][Full Text] [Related]
26. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
[TBL] [Abstract][Full Text] [Related]
27. Androgens and bone density in women with hypopituitarism.
Miller KK; Biller BM; Hier J; Arena E; Klibanski A
J Clin Endocrinol Metab; 2002 Jun; 87(6):2770-6. PubMed ID: 12050248
[TBL] [Abstract][Full Text] [Related]
28. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sulfasalazine treatment but not with sex hormones.
Tengstrand B; Hafström I
J Rheumatol; 2002 Nov; 29(11):2299-305. PubMed ID: 12415584
[TBL] [Abstract][Full Text] [Related]
30. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women.
Hall GM; Spector TD; Griffin AJ; Jawad AS; Hall ML; Doyle DV
Arthritis Rheum; 1993 Nov; 36(11):1510-6. PubMed ID: 8240428
[TBL] [Abstract][Full Text] [Related]
31. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
Földes J; Lakatos P; Zsadányi J; Horváth C
Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
[TBL] [Abstract][Full Text] [Related]
32. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
Diamond T; McGuigan L; Barbagallo S; Bryant C
Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
[TBL] [Abstract][Full Text] [Related]
33. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
Cauza E; Etemad M; Winkler F; Hanusch-Enserer U; Partsch G; Noske H; Dunky A
J Clin Pharm Ther; 2004 Oct; 29(5):431-6. PubMed ID: 15482386
[TBL] [Abstract][Full Text] [Related]
34. [Study of bone mineral density in postmenopausal women with rheumatoid arthritis treated with low dose glucocorticoids].
Nolla JM; Fiter J; Gómez Vaquero C; Mateo L; Valverde J; Roig Escofet D
Med Clin (Barc); 2000 Apr; 114(12):452-3. PubMed ID: 10846698
[TBL] [Abstract][Full Text] [Related]
35. Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.
Sambrook P; Birmingham J; Champion D; Kelly P; Kempler S; Freund J; Eisman J
J Rheumatol; 1992 Mar; 19(3):357-61. PubMed ID: 1533677
[TBL] [Abstract][Full Text] [Related]
36. High serum prolactin levels in men with rheumatoid arthritis.
Mateo L; Nolla JM; Bonnin MR; Navarro MA; Roig-Escofet D
J Rheumatol; 1998 Nov; 25(11):2077-82. PubMed ID: 9818647
[TBL] [Abstract][Full Text] [Related]
37. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
[TBL] [Abstract][Full Text] [Related]
38. Androgen deficiency and bone mineral density in men with rheumatoid arthritis.
Stafford L; Bleasel J; Giles A; Handelsman D
J Rheumatol; 2000 Dec; 27(12):2786-90. PubMed ID: 11128664
[TBL] [Abstract][Full Text] [Related]
39. Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study.
Ghebre MA; Hart DJ; Hakim AJ; Kato BS; Thompson V; Arden NK; Spector TD; Zhai G
Calcif Tissue Int; 2011 Oct; 89(4):295-302. PubMed ID: 21789637
[TBL] [Abstract][Full Text] [Related]
40. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy.
Hall GM; Spector TD; Delmas PD
Arthritis Rheum; 1995 Jul; 38(7):902-6. PubMed ID: 7612039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
